JP2024102242A5 - - Google Patents

Download PDF

Info

Publication number
JP2024102242A5
JP2024102242A5 JP2024075358A JP2024075358A JP2024102242A5 JP 2024102242 A5 JP2024102242 A5 JP 2024102242A5 JP 2024075358 A JP2024075358 A JP 2024075358A JP 2024075358 A JP2024075358 A JP 2024075358A JP 2024102242 A5 JP2024102242 A5 JP 2024102242A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid sequence
utr
absent
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2024075358A
Other languages
English (en)
Japanese (ja)
Other versions
JP7898475B2 (ja
JP2024102242A (ja
Filing date
Publication date
Priority claimed from PCT/US2019/065874 external-priority patent/WO2020123753A2/en
Application filed filed Critical
Publication of JP2024102242A publication Critical patent/JP2024102242A/ja
Publication of JP2024102242A5 publication Critical patent/JP2024102242A5/ja
Application granted granted Critical
Publication of JP7898475B2 publication Critical patent/JP7898475B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2024075358A 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム Active JP7898475B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862778851P 2018-12-12 2018-12-12
US201862778866P 2018-12-12 2018-12-12
US62/778,866 2018-12-12
US62/778,851 2018-12-12
PCT/US2019/065874 WO2020123753A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering intracellular therapeutic modalities
JP2021533523A JP2022514501A (ja) 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2021533523A Division JP2022514501A (ja) 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム

Publications (3)

Publication Number Publication Date
JP2024102242A JP2024102242A (ja) 2024-07-30
JP2024102242A5 true JP2024102242A5 (cg-RX-API-DMAC10.html) 2024-10-31
JP7898475B2 JP7898475B2 (ja) 2026-07-31

Family

ID=69160334

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533523A Withdrawn JP2022514501A (ja) 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム
JP2024075358A Active JP7898475B2 (ja) 2018-12-12 2024-05-07 細胞内治療モダリティを送達するためのアネロソーム

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2021533523A Withdrawn JP2022514501A (ja) 2018-12-12 2019-12-12 細胞内治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (1) US20220040117A1 (cg-RX-API-DMAC10.html)
EP (1) EP3894567A2 (cg-RX-API-DMAC10.html)
JP (2) JP2022514501A (cg-RX-API-DMAC10.html)
KR (1) KR20210131308A (cg-RX-API-DMAC10.html)
CN (1) CN114127302A (cg-RX-API-DMAC10.html)
AU (1) AU2019396516B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009282A2 (cg-RX-API-DMAC10.html)
CA (1) CA3119339A1 (cg-RX-API-DMAC10.html)
IL (1) IL283771A (cg-RX-API-DMAC10.html)
MX (1) MX2021006941A (cg-RX-API-DMAC10.html)
WO (1) WO2020123753A2 (cg-RX-API-DMAC10.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3121528A1 (en) 2018-12-12 2020-06-18 Flagship Pioneering Innovations V, Inc. Anellosomes and methods of use
JP2022513459A (ja) * 2018-12-12 2022-02-08 フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド タンパク質代替治療モダリティを送達するためのアネロソーム
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
US20240197823A1 (en) * 2021-02-12 2024-06-20 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Cationic antimicrobial peptides and uses thereof
TW202334423A (zh) 2021-12-15 2023-09-01 美商旗艦先鋒創新公司 表面經修飾之病毒顆粒及模組化之病毒顆粒
AU2023272105A1 (en) * 2022-05-19 2024-10-03 Flagship Pioneering Innovations V, Inc. Compositions comprising modified anellovirus capsid proteins and uses thereof
US20240415978A1 (en) * 2023-06-14 2024-12-19 Flagship Pioneering Innovations V, Inc. Anellovectors for delivery of effectors to the central nervous system
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
CA3066750A1 (en) * 2017-06-13 2018-12-20 Flagship Pioneering Innovations V, Inc. Compositions comprising curons and uses thereof

Similar Documents

Publication Publication Date Title
JP2024100936A5 (cg-RX-API-DMAC10.html)
JP2024099834A5 (cg-RX-API-DMAC10.html)
JP2024099833A5 (cg-RX-API-DMAC10.html)
AU2026202070A1 (en) Modified AAV capsid polypeptides for treatment of muscular diseases
JP2023113843A5 (cg-RX-API-DMAC10.html)
JP2003522514A5 (cg-RX-API-DMAC10.html)
JP2023549357A5 (cg-RX-API-DMAC10.html)
JP2024500036A5 (cg-RX-API-DMAC10.html)
JP2005509420A5 (cg-RX-API-DMAC10.html)
JP2024531728A5 (cg-RX-API-DMAC10.html)
JP2003503355A5 (cg-RX-API-DMAC10.html)
JPWO2020218419A5 (cg-RX-API-DMAC10.html)
JP2025093955A5 (cg-RX-API-DMAC10.html)
JP2023530278A5 (cg-RX-API-DMAC10.html)
JP2024084849A5 (cg-RX-API-DMAC10.html)
Ward et al. Structural homologies between RNA gene segments 10 and 11 from UK bovine, simian SA11, and human Wa rotaviruses
JP2023087682A5 (cg-RX-API-DMAC10.html)
CN108018267A (zh) 一种靶向表观基因调控抗乙型肝炎病毒分子HBx1C及其应用
ES2400805T3 (es) Método para amplificar una secuencia de ADN desconocida adyacente a una secuencia conocida
JP2021508496A5 (cg-RX-API-DMAC10.html)
JP2024520691A5 (cg-RX-API-DMAC10.html)
JPWO2023214512A5 (cg-RX-API-DMAC10.html)
JP2003507029A5 (cg-RX-API-DMAC10.html)
JPWO2023120658A5 (cg-RX-API-DMAC10.html)
JP2022551732A5 (cg-RX-API-DMAC10.html)